Genscript Biotech Corp - ESG Rating & Company Profile powered by AI
This SDG assessment for Genscript Biotech Corp represents its transparency towards the UN SDGs. Alternative corporations in the scoring industry group for Genscript Biotech Corp are shown. Scroll down to the bottom of the webpage for potential risks for Genscript Biotech Corp based on industry, location and marketcap.
Genscript Biotech Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 1.0, social score of 1.0 and governance score of 2.3.
1.4
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1715 | Polaris Group | 1.6 | Low |
1715 | RenovaCare Inc | 1.6 | Low |
1747 | Genscript Biotech Corp | 1.4 | Low |
1747 | Chembio Diagnostics Inc | 1.4 | Low |
1747 | Pharmaron Beijing Co Ltd | 1.4 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Genscript Biotech Corp have an accelerator or VC vehicle to help deliver innovation?
Does Genscript Biotech Corp disclose current and historical energy intensity?
Does Genscript Biotech Corp report the average age of the workforce?
Does Genscript Biotech Corp reference operational or capital allocation in relation to climate change?
Does Genscript Biotech Corp disclose its ethnicity pay gap?
Does Genscript Biotech Corp disclose cybersecurity risks?
Does Genscript Biotech Corp offer flexible work?
Does Genscript Biotech Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Genscript Biotech Corp disclose the number of employees in R&D functions?
Does Genscript Biotech Corp conduct supply chain audits?
Does Genscript Biotech Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Genscript Biotech Corp conduct 360 degree staff reviews?
Does Genscript Biotech Corp disclose the individual responsible for D&I?
Does Genscript Biotech Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Genscript Biotech Corp disclose current and / or historical scope 2 emissions?
Does Genscript Biotech Corp disclose water use targets?
Does Genscript Biotech Corp have careers partnerships with academic institutions?
Did Genscript Biotech Corp have a product recall in the last two years?
Does Genscript Biotech Corp disclose incidents of discrimination?
Does Genscript Biotech Corp allow for Work Councils/Collective Agreements to be formed?
Has Genscript Biotech Corp issued a profit warning in the past 24 months?
Does Genscript Biotech Corp disclose parental leave metrics?
Does Genscript Biotech Corp disclose climate scenario or pathway analysis?
Does Genscript Biotech Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Genscript Biotech Corp disclose the pay ratio of women to men?
Does Genscript Biotech Corp support suppliers with sustainability related research and development?
Does Genscript Biotech Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Genscript Biotech Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Genscript Biotech Corp involved in embryonic stem cell research?
Does Genscript Biotech Corp disclose GHG and Air Emissions intensity?
Does Genscript Biotech Corp disclose its waste policy?
Does Genscript Biotech Corp report according to TCFD requirements?
Does Genscript Biotech Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Genscript Biotech Corp disclose energy use targets?
Does Genscript Biotech Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Genscript Biotech Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Genscript Biotech Corp
These potential risks are based on the size, segment and geographies of the company.
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life Science Services and Products segment provides research services in various categories, including gene synthesis and molecular cloning, oligonucleotide synthesis, protein engineering, peptide synthesis, antibody development, molecular diagnostics tools, and genome editing materials for use in basic biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and food industry. The Biologics Development Services segment offers various services, such as antibody drug discovery, antibody drug pre-clinical and clinical development, plasmid and virus pre-clinical development, and plasmid and virus clinical development for therapeutic antibodies, as well as gene and cell therapy development and biologics discovery and development services for pharmaceutical, biotech, government, and academic customers. The Industrial Synthetic Biology Products segment constructs non-pathogenic microbial strains; and develops and produces industrial enzymes for food processing, feed, pharmaceutical, and chemical industries. The Cell Therapy segment discovers and develops chimeric antigen receptor T-cell therapies for the treatment of liquid and solid tumors. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.